[(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine

C25H26ClN9O — CID 164851067

IUPAC[(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine
SMILESCc1cc([C@@]2(CN)[C@@H]3CCN(c4cnc5c(-c6ccc7nn(C)c(C)c7c6Cl)[nH]nc5n4)C[C@@H]32)no1
InChIInChI=1S/C25H26ClN9O/c1-12-8-18(33-36-12)25(11-27)15-6-7-35(10-16(15)25)19-9-28-23-22(30-31-24(23)29-19)14-4-5-17-20(21(14)26)13(2)34(3)32-17/h4-5,8-9,15-16H,6-7,10-11,27H2,1-3H3,(H,29,30,31)/t15-,16+,25+/m1/s1
InChIKeyFSVRQAPFDUETIJ-TWKFVSLJSA-N
MW504.00 g/mol
LogP3.52
Rot. Bonds4

About [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine

[(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine (PubChem CID 164851067) has the molecular formula C25H26ClN9O and a molecular weight of 504.00 g/mol. Its IUPAC name is [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine.

Molecular Properties

Compound Name[(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine
PubChem CID164851067
Molecular FormulaC25H26ClN9O
Molecular Weight504.00 g/mol
Exact Mass503.19
IUPAC Name[(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine
SMILESCc1cc([C@@]2(CN)[C@@H]3CCN(c4cnc5c(-c6ccc7nn(C)c(C)c7c6Cl)[nH]nc5n4)C[C@@H]32)no1
InChIInChI=1S/C25H26ClN9O/c1-12-8-18(33-36-12)25(11-27)15-6-7-35(10-16(15)25)19-9-28-23-22(30-31-24(23)29-19)14-4-5-17-20(21(14)26)13(2)34(3)32-17/h4-5,8-9,15-16H,6-7,10-11,27H2,1-3H3,(H,29,30,31)/t15-,16+,25+/m1/s1
InChIKeyFSVRQAPFDUETIJ-TWKFVSLJSA-N
XLogP3.52
TPSA127.57 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500504.00
LogP ≤ 53.52
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine?
The IUPAC name of [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine (CID 164851067) is [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine.
What is the SMILES notation for [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine?
The canonical SMILES for [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine is Cc1cc([C@@]2(CN)[C@@H]3CCN(c4cnc5c(-c6ccc7nn(C)c(C)c7c6Cl)[nH]nc5n4)C[C@@H]32)no1.
What is the InChIKey of [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine?
The InChIKey is FSVRQAPFDUETIJ-TWKFVSLJSA-N. The full InChI is InChI=1S/C25H26ClN9O/c1-12-8-18(33-36-12)25(11-27)15-6-7-35(10-16(15)25)19-9-28-23-22(30-31-24(23)29-19)14-4-5-17-20(21(14)26)13(2)34(3)32-17/h4-5,8-9,15-16H,6-7,10-11,27H2,1-3H3,(H,29,30,31)/t15-,16+,25+/m1/s1.
What are the key properties of [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine?
[(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine has a molecular weight of 504.00 g/mol, XLogP of 3.52, 4 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,6R,7S)-3-[3-(4-chloro-2,3-dimethylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(5-methyl-1,2-oxazol-3-yl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine is sourced from PubChem (CID 164851067), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).